Latest filing published 14 May 2019 for Sonnet BioTherapeutics Holdings, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Russell Jacob Page: trading record in brief
Russell Jacob Page discloses dealings in 2 companies, chiefly Sonnet BioTherapeutics Holdings, Inc. and Diamond Hill Financial Trends Fund, Inc. Between 25 August 2008 and 12 April 2019, the trades on record add up to 5 filings.
On the market, this insider has only ever bought: 2 purchases, €29k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants.
The latest filing, published on 14 May 2019, reports a share grant in Sonnet BioTherapeutics Holdings, Inc. The most recent open-market purchase was published on 30 July 2015, 4,119 days ago. The median gap between a trade and its publication by SEC (Form 4) is 32 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Russell Jacob Page
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,304 shares0Common StockSEC:0001493152-19-007106:0
- 1,000 shares@ US$4.00Common StockSEC:0001493152-15-003252:0Canonical exit: 7 Sept 2010 (T+90)
- 6,667 shares@ US$1.73Common StockSEC:0001493152-15-003252:1
- 5,700 shares@ US$12.90Shares of Beneficial InterestSEC:0001418495-13-000004:0
- 3,700 shares@ US$10.00Shares of Beneficial InterestSEC:0000852954-08-000004:0Canonical exit: 23 Nov 2008 (T+90)
5 of 5 declarations